NFKB1 and acute kidney injury: Celastrol has also been effective against mesangioproliferative glomerulonephritis (Guo et al., 2017), recent studies (Chu et al., 2014) have additionally reported that Celastrol ameliorates IR-AKI, which correlates with inhibiting NF-κB activation and inflammation.